baber/WOPTO huggingface dataset:
Patent NZ-523885-A (NZ)
Title: A sampling tool for extracting organic samples such as meat
Inventor: GRAHAM DONALD MICHAEL
IPC: G01N1/08
Filed: 2003-01-29
Abstract: Disclosed is a sampling tool that includes a tool head with a sample retaining portion characterised in that, the said sampling tool further includes a fluid conduit extending from the sample-retaining portion through the tool head. The said tool head is selected from the group that includes a conical tool having a pointed penetrating tip, with said sample-retaining portion formed from a hollow inner volume open at the base with a sharpened circumference, a spade/chisel shaped tool, with a sample-retaining portion formed from an opening on a reverse aspect to a cutting/sharpened edge of said spade/chisel shape, a screw or auger-shaped tool with a hollow void forming said sample- retaining portion and a pair of opposed cutting surfaces, with a sample retaining portion formed within one of said opposed surfaces.
Patent NZ-525592-A (NZ)
Title: 1-Aryl- or 1-alkylsufonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
Inventor: KELLY MICHAEL GERARD
IPC: C07D413/12
Filed: 2001-10-31
Abstract: The application discloses compound I (see below), wherein the variables are described in the specification. The compound can be used in the preparation of a pharmaceutical composition for the treatment of motor disorders, anxiety disorders or cognitive disorders including neurodegenerative disorders.
Patent NZ-530190-A (NZ)
Title: Dynamically controlling a multifunctional peripheral deviceÆs touch panel interface from an external networked computer
Inventor: CONLEY MICHAEL
IPC: H04L29/08
Filed: 2001-11-26
Abstract: A system for providing user interface (UI) display and processing information to a touch panel provided with a multifunctional peripheral (MFP) device and controlled by a computer disposed internally within the MFP and connected to an external data communications network. The system comprises in combination: (a) An external computer connected on the network remotely from the MFP; and (b) The external computer provided with software adapted for remotely providing information data back to the MFP deviceÆs internal computer, via the network, for dynamically changing the UI display and behavior during run time of the system.
Patent NZ-531826-A (NZ)
Title: An information transmission system providing information such as inspirational messages or educational content to subscribers via telephone calls
Inventor: MAYELL MICHAEL EDWARD JOHN
IPC: H04Q7/20
Filed: 2002-09-19
Abstract: A method of transmitting information using an information transmission system adapted to transmit information to a plurality of subscribers comprises: (i) receiving at least one electronic transmission of source information from at least one content provider, wherein the source information incorporates a plurality of subscriber details and content information and (ii) initiating a telephone call to each of the plurality of subscribers detailed to deliver at least a portion of the content information supplied wherein the time at which the call is initiated is controlled by a schedule of call times supplied by the subscriber being called.
Patent NZ-536046-A (NZ)
Title: High dosage tablet forms of imatinib mesylate
Inventor: LUFTENSTEINER CHRISTIAN-PETER
IPC: A61K47/32
Filed: 2003-04-22
Abstract: Disclosed is a tablet comprising a pharmacologically effective amount of Compound I of formula (1) or a pharmaceutically acceptable salt thereof in an amount from about 30% to 80% in weight of the active moiety based on the total weight of the tablet. A process for the preparation of the tablet is also disclosed, which process comprises (i) mixing the Compound I of formula (1) or pharmaceutically acceptable salts thereof and pharmaceutically acceptable excipients; (ii) wet-granulating; (iii) mixing with pharmaceutically acceptable excipient to form a mixture; and (iv) compressing the mixture obtained in step (iii) to form a tablet.
Patent NZ-537976-A (NZ)
Title: Hybrid and tandem expression of neisserial proteins
Inventor: PIZZA MARIAGRAZIA
IPC: C12N15/10
Filed: 2002-09-06
Abstract: Disclosed is a hybrid protein having formula: NH2-A-[-X-L-]n-B-COOH wherein L is an optional linker amino acid sequence, A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, and n is an integer greater than 1, and X is either: (a) an amino acid sequence provided as any one of SEQ ID NOs: 28 and 29; (b) an amino acid sequence having at least 70% sequence identity to any amino acid sequence from (a); or (c) an amino acid sequence comprising a functional fragment of at least 7 amino acids of any amino acid sequence from (a). Also disclosed is a hybrid protein having formula: NH2-A-[-X-L-]n-B-COOH wherein X is an amino acid sequence, L is an optional linker amino acid sequence, A is an optional N-terminal amino acid sequence, B is an optional C-terminal amino acid sequence, and n is an integer greater than 1, and wherein a first X moiety (-Xa-) has one of the following amino acid sequences: (a) an amino acid sequence provided as any one of SEQ ID NOs: 28 and 29; (b) an amino acid sequence having at least 70% sequence identity to any amino acid sequence from (a); or (c) an amino acid sequence comprising a functional fragment of at least 7 amino acids of any amino acid sequence from (a), and a second -X- moiety (-Xb-), wherein -Xb- has one of the following amino acid sequences: (d) SEQ IDs 32-477; (e) SEQ IDs 47 8-522; (f) SEQ IDs 523-2197; (g) SEQ IDs 2198-4357; (h) SEQ IDs 4358-4373; (i) SEQ ID 4374; (j) an amino acid sequence having at least 70% sequence identity to any amino acid sequence from (d) to (g); or (k) an amino acid sequence comprising a functional fragment of at least 7 amino acids of any amino acid sequence from (d) to (g). The proteins can be used in the manufacture of medicaments to treat Neisseria s.p. infections.
Patent NZ-539979-A (NZ)
Title: 2',5'-oligoadenylic acid analogues with antitumor activity
Inventor: KOIZUMI MAKOTO
IPC: C07H21/00
Filed: 2003-11-19
Abstract: A 2',5'-oligoadenylate analogue represented by the general formula (1) is disclosed, wherein m is 0; n is 0 or 1; and all other variables shown in formula (1) are as defined in the specification. These 2',5'-oligoadenylate analogues represented by the general formula (1) are stable and have a superior antitumor activity.
Patent NZ-544150-A (NZ)
Title: Biaryloxymethylarenecarboxylic acids
Inventor: CHU CHANG AN
IPC: C07D277/56
Filed: 2004-06-18
Abstract: Disclosed is a compound of formula (I) wherein the substituents are described within the specification. Also disclosed is the use of the above compound for the preparation of medicaments for treating or preventing a disease mediated by the activation of the glycogen synthase enzyme such as diabetes.
Patent NZ-544480-A (NZ)
Title: Consumable packaging for clear-binders
Inventor: MARCHAL JEAN-LUC ALBERT VITAL
IPC: E01C19/10
Filed: 2003-05-30
Abstract: A consumable packaging composition is provided for packaging clear-binders, made of one or several packaging materials, alone or in combination, such as plastics, polymers and extenders, and which melting point is adjusted so that the packaging material melts when in contact wit the hot aggregates as methods of using them, are also disclosed. Optionally, and prior to packaging, the clear-binder may be mixed together with one or several color pigments used for production of colored mixes depending on the end-user requirements. In a preferred practice, the size of the packaged clear-binder product containers is adjusted such that, after transport and storage, the packaged material together with the packaging material can be directly incorporated along any of the steps of a production process that uses clear-binders. The packaged clear-binder material permits handling and manipulation to be reduced to the minimum necessary, thus avoiding the need for pre-heating and hot-storage of clear-binders.
Patent NZ-547048-A (NZ)
Title: Soft case luggage with wheels and handle and zipper
Inventor: SELVI SEDAT
IPC: A45C3/00
Filed: 2004-10-20
Abstract: A suitcase is disclosed. The suitcase is wheeled and includes moulded lid (1) and base (2) sections that comprise foamed plastics material and which are able to maintain their shape in the absence of perimeter framing and reinforcing panels. The two sections are hinged together by a zip fastener (3) which also allows the volume of the suitcase to be varied.
Patent NZ-548426-A (NZ)
Title: Defensive anti-intrusion vegetal hedge and method for the production thereof
Inventor: SOUPE DANIEL
IPC: A01G9/02
Filed: 2004-12-13
Abstract: Disclosed is a defensive anti-intrusion vegetal hedge for the protection of a property. The hedge comprises thorny plants, wherein said plants are planted along a line defining the area to be protected in one or two rows, characterized in that the branches of said plants are linked to neighbouring plants by interweaving said branches and/or by binding said branches by the ends thereof, further characterized in that it incorporates framing elements having pointed and/or cutting parts.
Patent NZ-554243-A (NZ)
Title: Triple lumen catheter
Inventor: ABE KAZUHIRO
Filed: 2005-09-30
Abstract: A triple lumen catheter comprises a transfusion lumen (4), a blood feeding lumen (2) and a blood removing lumen (3). The transfusion lumen (4) has a distal end and a leading end portion (12, 12A), the leading end portion progressively reducing in diameter to a proximal end. A transfusion port (4a) is formed in the proximal end of the transfusion lumen. The blood feeding lumen (2) has a blood feeding port (2a) in a region of the proximal end of the leading end portion, the blood feeding port opening at least partially in an axial direction of the leading end portion. The blood removing lumen (3) includes a pair of blood removing ports (3a, 3b) provided in opposite side walls of the catheter, the blood removing lumen extending from a distal end at least to the blood removing ports.
Patent NZ-560206-A (NZ)
Title: The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
Inventor: MAUS JOACHIM
IPC: A61P11/00
Filed: 2006-03-10
Abstract: Provided is a combination of R1R-glycopyrrolate or one of its physiologically acceptable salts and at least one leukotriene inhibitor for the treatment of respiratory diseases selected from allergic rhinitis, bronchial asthma and COPD. Also provided is the use of the combination for the production of a pharmaceutical to treat said diseases.
Patent NZ-562781-A (NZ)
Title: Allium transformation
Inventor: EADY COLIN CHARLES
IPC: C12N15/82
Filed: 2007-10-24
Abstract: Provided is a method of transforming cells from an Allium plant species with a polynucleotide of interest comprising the steps of: (i) isolating a section of leaf from the Allium plant to be transformed; (ii) co-culturing the section of leaf with Agrobacterium containing one or more suitable vectors comprising the polynucleotide of interest for a length of time sufficient to achieve transfer of the polynucleotide sequence of interest into one or more plant leaf cells; and (iii) transferring the section of leaf to a selection medium that allows for the selection of transformed Allium plant cells. Further provided are Allium plants transformed by the method.
Patent NZ-565513-A (NZ)
Title: Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-1-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
Inventor: HAMON CHRISTIAN
IPC: C07D401/12
Filed: 2006-07-26
Abstract: Disclosed is a set of two or more mass labels, wherein each label in the set is a mass label for labelling and detecting a biological molecule by mass spectroscopy, which label comprise the following structure: X-L-M wherein X is a mass marker moiety of formula (X) wherein the cyclic unit is aromatic or aliphatic and comprises from 0-3 double bonds independently between any two adjacent atoms; each Z is independently N, N(R1), C(R1), CO, C-O(R1), C(R1)2, O or S; X is N, C or C(R1) each R1 is independently H, a substituted or unsubstituted straight or branched Cr C6 alkyl group, a substituted or unsubstituted aliphatic cyclic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted heterocyclic group; and y is an integer from 0-10, L is a cleavable linker comprising an amide bond and M is a mass normalization moiety; and wherein each mass normalisation moiety ensures that a mass label has a desired aggregate mass.
Patent NZ-568997-A (NZ)
Title: Milking system and method for generating and communicating error messages in such a milking system
Inventor: CALDENIUS THOMAS
IPC: A01J5/007
Filed: 2006-12-13
Abstract: A milking system comprises a plurality of apparatuses (11a-g) and a method for generating and communicating messages in the milking system are disclosed. Each of the apparatuses comprises a device (12a-g) for performing an action related to the operation of the milking system; a microprocessor (13a-g); an error message generating system (14a-g) for generating messages (21) about the operation of the apparatuses such as error messages; and means (15a-g) for communicating the messages to all other ones of the apparatuses. Each of the messages comprises information about errors that have occurred in the apparatus and/or actions that have been performed by the apparatus such as the nature (22), severity (23) and physical location of the error. Each message is interpretable by all other ones of the apparatuses.
Patent NZ-569702-A (NZ)
Title: Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
Inventor: WANG HAITAO
IPC: A61P7/00
Filed: 2007-01-25
Abstract: Disclosed is a fusion protein having a prolonged half-life in vivo in comparison to naturally occurring or recombinant native human erythropoietin comprising: (a) a naturally occurring human erythropoietin molecule having a cysteine residue proximate to a C terminal thereof; and (b) a human IgG Fc fragment comprising a hinge region, wherein the N terminal of said Fc fragment is linked to said C terminal of said erythropoietin molecule and wherein said Fc fragment is naturally occurring except for a mutation replacing a cysteine residue of said hinge region located nearest said erythropoietin molecule with a non-cysteine residue, whereby the first cysteine residue of said hinge region located nearest said N terminal is spaced at least 17 amino acids apart from said cysteine residue of said erythropoietin molecule.
Patent NZ-577910-A (NZ)
Title: Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
Inventor: HOOK DAVID
IPC: C07C227/22
Filed: 2008-01-10
Abstract: Disclosed are pyrrolidin-2-ones represented by general formula (I) methods for their preparation and their use in the preparation of NEP-inhibitors, particularly in the preparation of N-(3-carboxyl-1 -oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester.
Patent NZ-578066-A (NZ)
Title: Spring constructed from a piston and a cylinder containing a pre-pressurised compressible liquid
Inventor: ARAMIZU TERUO
IPC: F16F5/00
Filed: 2008-01-17
Abstract: Disclosed is a hydraulic pressure spring designed to not require a check valve. The spring comprises a hollow cylindrical cylinder having a threaded portion at least one end, one closure means which is threadedly engaged with the threaded portion at the one end of the cylinder and closes the one end of the cylinder, and another closure means which is provided at another end of the cylinder and closes the other end of the cylinder. A compressible liquid is sealed in an interior of the cylinder and is pressurized to a predetermined pressure. A rod is passed through the one closure means or the another closure means movably in an axial direction and causes the liquid in the interior of the cylinder to undergo a pressure rise as the rod enters the interior of the cylinder. One end of the rod is disposed in the interior of the cylinder without being disposed outside of the cylinder, the other end of the rod being disposed outside of the cylinder. The liquid sealed in the interior of the cylinder is pressurized to a predetermined level by the threaded insertion of the one closure means into the threaded portion of the cylinder. The threaded portion of the cylinder being constituted by an external thread formed on an outer peripheral surface of the cylinder at the one end. The one closure means includes a closure member having on its inner peripheral surface an internal thread threadedly engaged with the external thread formed on the outer peripheral surface of the cylinder at the one end. A plug member is fitted to an inner peripheral surface of the cylinder at the one end by being pressed by the closure member in the axial direction and toward the other end of the cylinder.
Patent NZ-580418-A (NZ)
Title: T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
Inventor: LI XIAODONG
IPC: A23L27/00
Filed: 2004-08-06
Abstract: A non-naturally occurring compound that specifically binds to a T1R2/T1R3 receptor composed of hT1R2/hT1R3, having a potency as a modulator of the T1R2/T1R3 receptor as determined by an EC50 of less than about 1 mM or by an EC50 ratio of at least 1.20, wherein the non-naturally occurring compound is an amide compound.
Patent NZ-580611-A (NZ)
Title: Use of acidifying agent for promoting micronutrient uptake
Inventor: GOODWIN MARK
IPC: C05G3/80
Filed: 2008-04-24
Abstract: An agronomic carrier selected from the group consisting of seeds; nitrogen, phosphate, potassium, sulfur, calcium, or magnesium fertilizer products; micronutrient fertilizer products; secondary products; urea, MAP, DAP or potash prills; a dry fertilizer; a powder fertilizer; a fertilizer granule or a granular fertilizer; and inert or biodegradable pellets, said agronomic carrier being coated with an effective amount of an acidifying agent selected from the group consisting of lignite, gibberellic acid, citric acid, sodium metabisulfite, malic acid, oxalic acid, succinate, acetic acid, butyric acid, valeric acid, lactic acid, pyruvic acid, malonic acid, formic acid, erythronic acid, tetronic acid, and fumaric acid, wherein the acidifying agent is ground to a mesh size of at least 100 and is applied as a powder to the agronomic carrier at 0.1-2.0 percent (w/w) of the agronomic carrier.
Patent NZ-587827-A (NZ)
Title: Prohibiting unnecessary scheduling requests for uplink grants
Inventor: MOBERG PETER
IPC: H04W72/12
Filed: 2009-03-19
Abstract: 587827 A method and an apparatus for uplink communications from a wireless terminal (14) to a network over a radio interface are disclosed. The apparatus comprises radio circuitry (32) for communicating with the network, a buffer (36) that stores data and a controller (38). The controller is configured to detect data in the buffer to be transmitted by the wireless terminal, to determine a priority associated with the detected data; to determine that a future uplink radio resource is scheduled for use by the wireless terminal; to transmit an uplink transmission scheduling request to the network if the determined priority is a first priority; and to transmit the data using the future uplink radio resource when the determined priority is the second priority. Also disclosed is a base station (12) for use with the wireless terminal (14) comprising an uplink transmissions scheduler (18) coupled to radio communications circuitry (20). The uplink transmissions scheduler is configured to receive and grant scheduling requests and receive data transmitted using the uplink grant.
Patent NZ-588913-A (NZ)
Title: Liver cancer drug
Inventor: KINOSHITA YASUKO
IPC: A61K31/404
Filed: 2009-03-19
Abstract: Disclosed is a pharmaceutical composition for treating or preventing a liver cancer comprising a combination of a chemotherapeutic agent and an anti-glypican 3 antibody, wherein the chemotherapeutic agent is selected from Sorafenib or Sunitinib and the anti-glypican 3 antibody has cytotoxicity. Also disclosed is a use of an anti-glypican 3 antibody in the manufacture of a medicament for treating or preventing a weight loss caused by a treatment of a liver cancer by a chemotherapeutic agent, wherein the chemotherapeutic agent is selected from Sorafenib or Sunitinib and the anti-glypican 3 antibody has cytotoxicity, and wherein the anti-glypican 3 antibody is formulated for concomitant administration with the chemotherapeutic agent.
Patent NZ-591202-A (NZ)
Title: Conical cup with inwardly projecting shoulder sufficiently high to allow stacking of a like container and facilitate easy separation
Inventor: D AMATO GIANFRANCO
IPC: B31B50/25
Filed: 2006-10-13
Abstract: A container has an inner wall (34) and an outer wall (35), in each case narrowing conically downwards. The walls are at least joined together at the upper edge (36) of the container, wherein on the inner side of the inner wall a de-nesting means, protruding inwards, is formed as a stacking projection. On that, another container when inserted in the container is supported. A distance (48) between said stacking projection and the bottom of the projection, is at least slightly larger than a distance between said bottom and a potential contact starting point (if the shoulder were absent) at which two containers would contact each other when located co-axially, so as to prevent binding during separation of containers.
Patent NZ-592335-A (NZ)
Title: Lumbar support system for a chair including multiple springs
Inventor: LAPOINTE LARRY P
IPC: A47C7/44
Filed: 2009-11-20
Abstract: Disclosed is an occupant lumbar support system (36) for a furniture member. The system has a flexible occupant lumbar support member (38) having first and second connection braces (94, 98). The lumbar support member is deflectable to any one of a plurality of occupant lumbar support positions. At least one guide rod (66, 68) is slidably disposed through both the first and second connection braces operating to slidingly guide the first and second connection braces during movement of one of the first and second connection braces toward or away from the other of the connection braces. A support tube (40) is oriented transverse to the at least one guide rod and rotatable to maintain continuous contact between the support tube and the at least one guide rod such that the support tube provides continuous contact support for a first end of the lumbar support member. A bracket (116) fixedly connected to the support tube. First and second biasing elements (118, 128) are each connected to the bracket and to a lumbar member actuation mechanism (102), the second biasing element having a spring constant and a biasing force greater than a spring constant and a biasing force of the first biasing element. In a fully retracted position of the lumbar support member the second biasing element is flexibly extended, with the second biasing element biasing force acting through an over-centre force path permitting the biasing force of the first biasing element to retain the fully retracted position of lumbar support member.
Patent NZ-595596-A (NZ)
Title: Device and method for dosing or shutting off primary combustion air in the primary heating room of horizontal coke-oven chambers
Inventor: KIM RONALD
IPC: C10B15/02
Filed: 2010-02-13
Abstract: 595596 A device and method for shutting off and dosing primary combustion air to a coke oven chamber (4) is disclosed. At least one air feeder (2) for supply of primary combustion air is arranged in the top ceiling (5) of at least one coke oven chamber (4) of a coke oven bank or coke oven battery. The air feeder (2) possesses a cover (1) which covers the air feeder (2) and can be withdrawn gradually to partially open the air feeder (2). The cover (1) is connected to a rod (7) which can be moved in vertical direction by means of a mechanical device such that the cover (1) opens or closes the air feeder (2) by the vertical movement.